Status:
RECRUITING
Clinico-biological Collection to Investigate the Physiopathology of Systemic Autoimmune Diseases
Lead Sponsor:
University Hospital, Toulouse
Conditions:
Lupus Erythematosus
Scleroderma
Eligibility:
All Genders
6-99 years
Brief Summary
The aim of this project is to start a biological and clinical collection of patients presenting systemic autoimmune disease. This collection will provide appropriate biological samples to identify new...
Detailed Description
Autoimmune diseases group together less than a hundred different clinical entities which are for the most part rare pathologies but which, in combination, concern 5-8% of the adult population with a s...
Eligibility Criteria
Inclusion
- Patients with rare systemic autoimmune diseases (lupus, scleroderma, myositis for example),
- Patients with atypical presentations of documented or probable systemic autoimmune diseases,
- Patients receiving, or likely to receive new, innovative therapies (new molecule on the market, gene therapy, cell therapy, etc.).
Exclusion
- Known anemia and hemoglobin \<10 g / dl
- Patients under protective supervision (guardianship, curators)
- Pregnant or breastfeeding woman
Key Trial Info
Start Date :
April 4 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 4 2032
Estimated Enrollment :
3000 Patients enrolled
Trial Details
Trial ID
NCT05251415
Start Date
April 4 2022
End Date
April 4 2032
Last Update
March 29 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Purpan University Hospital
Toulouse, France, 31059